Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven K Burke

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|December 20, 2007
Phosphate is a uremic toxinSteven K Burke
Seminars in Nephrology|October 19, 2004
Arterial calcification in chronic kidney diseaseSteven K Burke
Kidney International|June 26, 2002
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patientsGlenn M Chertow, Steven K Burke, Paolo Raggi, et al.
Clinical Pharmacology in Drug Development|February 16, 2022
Effect of Phosphate Binders and a Dietary Iron Supplement on the Pharmacokinetics of a Single Dose of Vadadustat in Healthy AdultsSusan K Paulson, Jimena Martinez, Rishikesh Sawant, et al.
The Annals of Pharmacotherapy|March 16, 2002
Absorption of colesevelam hydrochloride in healthy volunteersDennis P Heller, Steven K Burke, David M Davidson, et al.
Clinical Pharmacokinetics|June 27, 2002
Sevelamer, a phosphate-binding polymer, is a non-absorbed compoundMelissa A Plone, John S Petersen, David P Rosenbaum, et al.
BMC Nephrology|August 12, 2025
A randomized trial to evaluate the pharmacokinetics, pharmacodynamics, and safety of vadadustat in patients with anemia associated with chronic kidney disease receiving hemodialysisPamela Navarro-Gonzales, Ajit Chavan, Don Wang, et al.
Advances in Renal Replacement Therapy|July 25, 2003
Meta-analysis of the effect of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patientsSteven K Burke, Maureen A Dillon, Douglas E Hemken, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 23, 2004
Determinants of progressive vascular calcification in haemodialysis patientsGlenn M Chertow, Paolo Raggi, Scott Chasan-Taber, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2003
Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiencyNobuo Nagano, Sonoe Miyata, Sachiko Obana, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|December 20, 2007
Phosphate is a uremic toxinSteven K Burke
Seminars in Nephrology|October 19, 2004
Arterial calcification in chronic kidney diseaseSteven K Burke
Kidney International|June 26, 2002
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patientsGlenn M Chertow, Steven K Burke, Paolo Raggi, et al.
Clinical Pharmacology in Drug Development|February 16, 2022
Effect of Phosphate Binders and a Dietary Iron Supplement on the Pharmacokinetics of a Single Dose of Vadadustat in Healthy AdultsSusan K Paulson, Jimena Martinez, Rishikesh Sawant, et al.
The Annals of Pharmacotherapy|March 16, 2002
Absorption of colesevelam hydrochloride in healthy volunteersDennis P Heller, Steven K Burke, David M Davidson, et al.
Clinical Pharmacokinetics|June 27, 2002
Sevelamer, a phosphate-binding polymer, is a non-absorbed compoundMelissa A Plone, John S Petersen, David P Rosenbaum, et al.
BMC Nephrology|August 12, 2025
A randomized trial to evaluate the pharmacokinetics, pharmacodynamics, and safety of vadadustat in patients with anemia associated with chronic kidney disease receiving hemodialysisPamela Navarro-Gonzales, Ajit Chavan, Don Wang, et al.
Advances in Renal Replacement Therapy|July 25, 2003
Meta-analysis of the effect of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patientsSteven K Burke, Maureen A Dillon, Douglas E Hemken, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 23, 2004
Determinants of progressive vascular calcification in haemodialysis patientsGlenn M Chertow, Paolo Raggi, Scott Chasan-Taber, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2003
Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiencyNobuo Nagano, Sonoe Miyata, Sachiko Obana, et al.
Pageof 5